A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and ОІ2 -microglobulin.

Melchardt, T, Troppan, K, Weiss, L, Hufnagl, C, Neureiter, D, Tränkenschuh, W, Hopfinger, G, Magnes, T, Deutsch, A, Neumeister, P, Hackl, H, Greil, R, Pichler, M, Egle, A. Br J Haematol. 2015, 168(2):239-245.

10th anniversary of the Austrian MDS Platform: aims and ongoing projects.

Burgstaller, S, Bettelheim, P, Krieger, O, Machherndl-Spandl, S, Nösslinger, T, Pleyer, L, Sill, H, Sperr, WR, Stauder, R, Valent, P, Pfeilstöcker, M. Wien Klin Wochenschr. 2015, 127(1-2): 12-15.

Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients.

Blank, PR, Filipits, M, Dubsky, P, Gutzwiller, F, Lux, MP, Brase, JC, Weber, KE, Rudas, M, Greil, R, Loibl, S, Szucs, TD, Kronenwett, R, Schwenkglenks, M, Gnant, M. Pharmacoeconomics. 2015, 33(2): 179-190.

A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors.

Dittrich, C, Fridrik, MA, Koenigsberg, R, Lee, C, Goeldner, R, Hilbert, J, Greil, R. Invest New Drugs. 2015, 33(2): 409-422.

Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.

Melchardt, T, Weiss, L, Hufnagl, C, Neureiter, D, Kemmerling, R, Morre, P, Boekstegers, A, Hopfinger, G, Auberger, J, Steinkirchner, S, Pleyer, L, Greil, R, Egle, A. Leuk Lymphoma. 2015, 56(2):353-360.

Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.

Them, NC, Bagienski, K, Berg, T, Gisslinger, B, Schalling, M, Chen, D, Buxhofer-Ausch, V, Thaler, J, Schloegl, E, Gastl, GA, Wolf, D, Strecker, K, Egle, A, Melchardt, T, Burgstaller, S, Willenbacher, E, Zagrijtschuk, O, Klade, C, Greil, R, Gisslinger, H, Kralovics, R. Am J Hematol. 2015, 90(4): 288-294.

CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanisms.

Hutterer, E, Asslaber, D, Caldana, C, Krenn, PW, Zucchetto, A, Gattei, V, Greil, R, Hartmann, TN. Br J Haematol. 2015, 169(2):286-289.

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.

Gnant, M, Mlineritsch, B, Stoeger, H, Luschin-Ebengreuth, G, Knauer, M, Moik, M, Jakesz, R, Seifert, M, Taucher, S, Bjelic-Radisic, V, Balic, M, Eidtmann, H, Eiermann, W, Steger, G, Kwasny, W, Dubsky, P, Selim, U, Fitzal, F, Hochreiner, G, Wette, V, Sevelda, P, Ploner, F, Bartsch, R, Fesl, C, Greil, R. Ann Oncol. 2015, 26(2):313-320.

VLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions.

Hinterseer, E, Stiefel, O, Neureiter, D, Kandler, G, Vogt, S, Hutter, J, Strasser, G, Greil, R, Hartmann, TN, Hopfinger, G. Leuk Lymphoma. 2015, 56(8): 2465-2467.

Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.

Kocher, F, Hilbe, W, Seeber, A, Pircher, A, Schmid, T, Greil, R, Auberger, J, Nevinny-Stickel, M, Sterlacci, W, Tzankov, A, Jamnig, H, Kohler, K, Zabernigg, A, Frotscher, J, Oberaigner, W, Fiegl, M. LUNG CANCER. 2015, 87(2): 193-200.